HCA250516P365000
- 6.40
- -3.30-34.02%
HCA Healthcare Newsroom
HCA Healthcare (HCA) Rebounded in Q1
HCA Healthcare, Inc. to Present at May Healthcare Conference
Possible Bearish Signals With HCA Healthcare Insiders Disposing Stock
Hyundai Capital America Implements DataScan's RiskGauge to Elevate Inventory Risk Management
HCA Healthcare | 10-Q: Q1 2025 Earnings Report
Is the Market Bullish or Bearish on HCA Healthcare?
Should You Investigate HCA Healthcare, Inc. (NYSE:HCA) At US$345?
Tenet Healthcare Q1 Results Exceed Expectations Due to Strong Volume, Cost Control, RBC Says
HCA Healthcare Approves New Compensation Program
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $355 to $390
HCA Healthcare Price Target Cut to $376.00/Share From $384.00 by RBC Capital
HCA Healthcare Is Maintained at Outperform by RBC Capital
HCA Healthcare Analyst Ratings
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Gilead Sciences (GILD)
HCA Healthcare Price Target Lowered to $361 From $377 at TD Cowen
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $370
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
RBC Lowers Price Target on HCA Healthcare to $376 From $384, Keeps Outperform Rating
Express News | HCA Healthcare Inc : Leerink Partners Cuts Target Price to $390.00 From $404.00
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)